[Prevention of preeclampsia]

Ann Fr Anesth Reanim. 2010 Mar;29(3):e31-5. doi: 10.1016/j.annfar.2010.02.014. Epub 2010 Mar 24.
[Article in French]

Abstract

Aspirin has shown efficacy in preventing PE with a 10 % incidence reduction. The treatment must be started between the 12(th) and 14(th) week of amenorrhea with a dose of 75 to 160 mg once daily. This treatment is all the more effective as it is given to a high risk population. The supplementation with 1,5 g of calcium per day appears effective as well in the prevention of PE, especially in the malnourished and young patents. Insufficient data is currently available to recommend antioxidant supplementation. Low molecular weight heparin is potentially beneficial in the prevention of PE, however its efficacy remains to be demonstrated and indications determined. Nitric oxide (NO) or NO releasers are not effective and can cause headaches. Diuretics reduce the birth weight without improving the incidence of PE.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Anticoagulants / therapeutic use
  • Antioxidants / therapeutic use
  • Aspirin / administration & dosage
  • Aspirin / therapeutic use
  • Calcium Compounds / therapeutic use
  • Diuretics / adverse effects
  • Diuretics / therapeutic use
  • Female
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Male
  • Malnutrition / complications
  • Nitric Oxide Donors / adverse effects
  • Nitric Oxide Donors / therapeutic use
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / therapeutic use
  • Pre-Eclampsia / prevention & control*
  • Pregnancy
  • Risk
  • Young Adult

Substances

  • Anticoagulants
  • Antioxidants
  • Calcium Compounds
  • Diuretics
  • Heparin, Low-Molecular-Weight
  • Nitric Oxide Donors
  • Platelet Aggregation Inhibitors
  • Aspirin